Investigating the association between educational attainment and allostatic load with risk of cancer mortality among African American women

Study design and participants We performed a retrospective cohort analysis using data from the National Health and Nutrition Examination Survey (NHANES), a representative sample of non-institutionalized US residents linked with the National Center for Health Statistics (NCHS) 2019 National Death Index (NDI) file. The NHANES program oversamples those aged 60 and older, Latinx and non-Hispanic […]

Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis

Trujillo JM, Nuffer W, Smith BA. GLP-1 receptor agonists: an updated review of head-to-head clinical studies. Ther Adv Endocrinol Metab. 2021;12:2042018821997320. Article  CAS  PubMed  PubMed Central  Google Scholar  Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311–22. […]

Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study

IDF Diabetes Atlas. https://www.diabetesatlas.org. Chen H, Chen G, Zheng X, Guo Y. Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study. BMJ. 2019;364:l969. Article  PubMed  PubMed Central  Google Scholar  Gregg EW, Sattar N, Ali MK. The changing face of diabetes complications. […]

Pediatric Perfusion Global Market Report 2023

New York, Aug. 24, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Pediatric Perfusion Global Market Report 2023” – https://www.reportlinker.com/p06486484/?utm_source=GNW V., Sorin Group, Medivators Inc., Cardinal Health Inc, Fluigent, Getinge AB, Xvivo Perfusion AB, and Masimo Corporation. The global pediatric perfusion market is expected to grow from $2.32 billion in 2022 to […]

Microarray Global Market Report 2023

New York, Aug. 24, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Microarray Global Market Report 2023” – https://www.reportlinker.com/p06486509/?utm_source=GNW , PerkinElmer Inc., Thermo Fisher Scientific Inc., Molecular Devices LLC, BioMerieux Inc., RayBiotech Life Inc., Diasorin Group, NextGen Sciences Inc., PathogenDx Inc., Schott Minifab AG, Full Moon Biosystems Inc. and CapitalBio Technology Co. […]

CDC Advisory Group Under Fire for Proposed Infection Control Guidelines

Nurses, patients, and professional groups are pushing for more rigorous infection control standards from the CDC following a preview of proposed changes to its isolation precaution guidelines and an advisory group meeting this week during which a vote on the changes was postponed. Opponents have said the changes, detailed in a presentation in June, are […]

Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project

IDF Diabetes atlas. 10th edition. Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson A-M, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407–18. Article  PubMed  Google Scholar  Sarwar N, Gao P, Kondapally Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. […]

Multiparameter prediction of myeloid neoplasia risk

Abstract The myeloid neoplasms encompass acute myeloid leukemia, myelodysplastic syndromes and myeloproliferative neoplasms. Most cases arise from the shared ancestor of clonal hematopoiesis (CH). Here we analyze data from 454,340 UK Biobank participants, of whom 1,808 developed a myeloid neoplasm 0–15 years after recruitment. We describe the differences in CH mutational landscapes and hematology/biochemistry test parameters […]

J&J Cuts R&D at Netherlands Infectious Disease, Vaccine Unit

Pictured: J&J business center in Switzerland/iStock, yuelan Johnson & Johnson appears to be winding down research at its infectious disease and vaccine unit, save for a few select programs, according to Fierce Biotech on Wednesday, citing sources familiar with the matter. A Janssen spokesperson said J&J is “planning to exit other R&D programs in ID&V,” though […]